Harnessing γδ T cells for B7-H3-targeting CAR therapy to enhance anti-tumor therapy in glioblastoma
Abstract Background Glioblastoma (GBM) remains largely incurable, in part because the highly immunosuppressive tumor microenvironment (TME) poses a major barrier to conventional therapies, including to chimeric antigen receptor (CAR)-T cell therapy. Compared with conventional αβ T cells, γδ T cells...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2026-03-01
|
| Edice: | Journal of Translational Medicine |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s12967-026-07994-6 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|